Current and resolved drug shortages and discontinuations reported to FDA, Food and Drug Administration (2024) Bydureon BCise highlights of prescribing information, Food and Drug Administration (2022) Ozempic highlights of prescribing information, Food and Drug Administration (2023) Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with Type 2 diabetes (Sustain 3): A 56-week, open-label, randomized clinical trial, Diabetes Care (2018) Label: Bydureon BCise, DailyMed (2023) Label: Ozempic, Daily Med (2023) GLP-1 receptor agonists and the risk of thyroid cancer, Diabetes Care (2023) Drug-drug interactions between glucagon-like peptide 1 receptor agonists and oral medications: A systematic review, Drug Safety (2024) The clinical efficacy and safety of glucagon-like peptide-1 (GLP-1) Agonists in adults with Type 2 diabetes mellitus, Clinical Medicine Insights: Endocrinology and Diabetes (2011) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

These investigations did not provide clear-cut results
doi:10.1016/j.amjcard.2018.12.018 76
Cancer / proliferation concern: Potentiating c-Met (a proto-oncogene product) raises a legitimate theoretical risk of promoting pre-existing or nascent malignancy
Oxides such as nano-titanium dioxide (TiO 2 ), nano-zinc oxide (ZnO), nano-silicon dioxide (SiO 2 ), and nano-cerium oxide (CeO 2 ) have a wide range of applications in the medical field
Treatment for Maturity Melanosis at FMS Skin and Hair Clinics While maturity melanosis is harmless and does not require medical treatment, many individuals seek treatment for cosmetic reasons